超重与肥胖是否影响中轴型脊柱关节炎疾病活动度评分:系统综述与荟萃分析
该研究纳入10篇文章进行系统综述与荟萃分析,评估超重/肥胖与中轴型脊柱关节炎患者BASDAI及ASDAS的关系。结果显示超重/肥胖者疾病活动度评分高于正常BMI者,但差异仅在肥胖与正常BMI比较时具有临床意义,且BASDAI较ASDAS更明显。
要点
- 超重/肥胖中轴型SpA患者BASDAI与ASDAS均高于正常BMI者。
- 肥胖与正常BMI间差异有统计学意义,超重与正常BMI间无统计学差异。
- 差异的临床意义主要体现在肥胖组,且BASDAI较ASDAS更明显。
核心结论
- 超重和肥胖的中轴型SpA患者相较正常BMI患者倾向于报告更高的疾病活动度评分。
- 该差异仅在肥胖与正常BMI比较时似具临床意义,且BASDAI较ASDAS更明显。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、PubMed和Web of Science。
- 纳入标准为成人中轴型SpA、按BMI分组、报告各组BASDAI/ASDAS的观察性研究。
- 采用Newcastle-Ottawa量表进行质量评价,随机效应模型合并均值差(MD)及95%CI。
- 最终纳入10篇文章。
主要发现
- 正常BMI与超重/肥胖组BASDAI的MD为-0.38(95%CI -0.56,-0.21;P < 0.0001)。
- 正常BMI与超重/肥胖组ASDAS的MD为-0.19(95%CI -0.29,-0.09;P < 0.0001)。
- 正常BMI与超重组BASDAI的MD为-0.09(95%CI -0.33,0.15;P = 0.45)。
- 正常BMI与肥胖组BASDAI的MD为-0.78(95%CI -1.07,-0.48;P < 0.0001)。
- 正常BMI与超重组ASDAS的MD为-0.02(95%CI -0.19,0.15;P = 0.79);与肥胖组ASDAS的MD为-0.42(95%CI -0.60,-0.23;P < 0.0001)。
临床怎么用
- 评估中轴型SpA疾病活动度时应考虑患者BMI状态,尤其肥胖可能抬高BASDAI评分。
- 对肥胖患者解读BASDAI/ASDAS时需谨慎,避免将体质量相关评分误判为疾病活动加重。
局限性
- 纳入研究均为观察性设计,仅10篇文章,可能存在异质性与混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of our systematic review and meta-analysis was to investigate whether overweight/obesity are associated with higher disease activity measures in patients with axial spondyloarthritis (SpA). METHODS: MEDLINE, PubMed, and Web of Science were searched using key terms corresponding to population (axial SpA patients), exposure (overweight/obesity), and outcome (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] and Ankylosing Spondylitis Disease Activity Score [ASDAS]). Predefined inclusion criteria were adult patients with axial SpA, exposure classified according to body mass index (BMI), BASDAI/ASDAS reported for each BMI group, and observational studies. The Newcastle-Ottawa Scale for cohort, cross-sectional, and case-control studies was used for quality check. Random-effects meta-analysis was used to pool results, which were expressed as the mean difference (MD) in BASDAI and ASDAS between BMI groups, with 95% confidence intervals (95% CIs). RESULTS: A total of 10 articles were included in the meta-analysis. The MD in BASDAI between normal BMI and overweight/obese patients was -0.38 (95% CI -0.56, -0.21; P < 0.0001); the MD in ASDAS between the same groups was -0.19 (95% CI -0.29, -0.09; P < 0.0001). The MD in BASDAI between normal BMI and overweight patients was -0.09 (95% CI -0.33, 0.15; P = 0.45), and the MD between normal BMI and obese patients was -0.78 (95% CI -1.07, -0.48; P < 0.0001). For ASDAS, the MD between normal BMI and overweight patients was -0.02 (95% CI -0.19, 0.15; P = 0.79), and the MD between normal BMI and obese patients was -0.42 (95% CI -0.60, -0.23; P < 0.0001). CONCLUSION: Overweight and obese patients with axial SpA tend to present higher disease activity scores compared to patients with a normal BMI. This difference seems to be clinically meaningful only for the comparison between obese patients and patients with normal BMI, and more for BASDAI than ASDAS.
引用
- Ortolan A, Lorenzin M, Felicetti M, et al. Do Obesity and Overweight Influence Disease Activity Measures in Axial Spondyloarthritis? A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2021. PMID: 32799405. doi:10.1002/acr.24416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。